Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

EMODIN CRS (15 MG)

EMODIN CRS (15 MG)

518-82-1

DISCOVER
PARTHENOLIDE CRS (15 MG)

PARTHENOLIDE CRS (15 MG)

ND

DISCOVER
HYDROXYCHLOROQUINE SULFATE CRS (70 MG)

HYDROXYCHLOROQUINE SULFATE CRS (70 MG)

747-36-4

DISCOVER
TAXIFOLIN CRS (15 MG)

TAXIFOLIN CRS (15 MG)

480-18-2

DISCOVER
HYDROXYCHLOROQUINE FOR SYSTEMSUITABILITY CRS (15 MG)

HYDROXYCHLOROQUINE FOR SYSTEMSUITABILITY CRS (15 MG)

747-36-4

DISCOVER
DEXAMETHASONE ACETATE FOR PEAK IDENTIFICATION CRS (10 MG)

DEXAMETHASONE ACETATE FOR PEAK IDENTIFICATION CRS (10 MG)

1177-87-3

DISCOVER
TRIAMCINOLONE HEXACETONIDE FOR SYSTEM SUITABILITY CRS (10 MG

TRIAMCINOLONE HEXACETONIDE FOR SYSTEM SUITABILITY CRS (10 MG

5611-51-8

DISCOVER
ESCITALOPRAM CRS (10 MG)

ESCITALOPRAM CRS (10 MG)

128196-01-0

DISCOVER
ERYTHROMYCIN ETHYLSUCCINATE FOR IMPURITY P IDENTIFICATION CR

ERYTHROMYCIN ETHYLSUCCINATE FOR IMPURITY P IDENTIFICATION CR

1264-62-6

DISCOVER
Erythromycin for impurity M identification CRS, 10mg

Erythromycin for impurity M identification CRS, 10mg

114-07-8

DISCOVER
ERYTHROMYCIN FOR SYSTEM SUITABILITY CRS (15 MG)

ERYTHROMYCIN FOR SYSTEM SUITABILITY CRS (15 MG)

114-07-8

DISCOVER
ERYTHROMYCIN LACTOBIONATE CRS(15 MG)

ERYTHROMYCIN LACTOBIONATE CRS(15 MG)

3847-29-8

DISCOVER